COVAX
Price
$15.19
Change
+$0.03 (+0.20%)
Updated
Jul 31 closing price
Net Assets
919.05M
UBVVX
Price
$89.26
Change
-$0.55 (-0.61%)
Updated
Jul 31 closing price
Net Assets
9.02B
Interact to see
Advertisement

COVAX vs UBVVX

COVAX vs UBVVX Comparison Chart in %
View a ticker or compare two or three
VS
COVAX vs. UBVVX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COVAX is a Buy and UBVVX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
UBVVX has more cash in the bank: 9.02B vs. COVAX (919M). UBVVX pays higher dividends than COVAX: UBVVX (1.59) vs COVAX (0.50). COVAX was incepted earlier than UBVVX: COVAX (24 years) vs UBVVX (9 years). COVAX (1.37) is less costly to investors than UBVVX (0.94). COVAX is a more actively managed with annual turnover of: 115.00 vs. UBVVX (35.00). UBVVX has a lower initial minimum investment than COVAX: UBVVX (0) vs COVAX (2000). COVAX annual gain was more profitable for investors over the last year : 17.74 vs. UBVVX (9.60). UBVVX return over 5 years is better than : 18.82 vs. COVAX (-17.40).
COVAXUBVVXCOVAX / UBVVX
Total Expense Ratio1.200.90133%
Annual Report Gross Expense Ratio1.370.94146%
Fund Existence24 years9 years-
Gain YTD18.30214.187129%
Front Load6%N/A-
Min. Initial Investment20000-
Min. Initial Investment IRAN/AN/A-
Net Assets919M9.02B10%
Annual Yield % from dividends0.501.5931%
Returns for 1 year17.749.60185%
Returns for 3 years-4.8014.27-34%
Returns for 5 years-17.4018.82-92%
Returns for 10 years0.58N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GGEAX25.510.41
+1.63%
Nationwide Schroders Global Eq A
FDSSX103.580.75
+0.73%
Fidelity Stock Selec
LMLSX44.010.14
+0.32%
ClearBridge Large Cap Value IS
FIDSX17.300.04
+0.23%
Fidelity Select Financials Port
SMCIX25.28-0.04
-0.16%
Shelton S&P Smallcap Index Investor